Jenifer Cooper
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,418 of the $4,108 with a category attached, or 83.2%. 24 manufacturers reported payments, led by AbbVie at 24.8% of the total. Among family clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 242 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$640
- Johnson & Johnson$576
- Sun Pharmaceutical Industries Inc.$461
- Pfizer$340
- Galderma Laboratories, L.p.$235
- plus $837 from 18 others
What the payments were for
- Food & beverage$3,41883%
- Education$69017%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $1,019 |
| Lilly USA, LLC | 42 | $640 |
| Johnson & Johnson | 17 | $576 |
| Sun Pharmaceutical Industries Inc. | 28 | $461 |
| Pfizer | 31 | $340 |
| Galderma Laboratories, L.p. | 6 | $235 |
| Sanofi | 5 | $128 |
| Novartis | 6 | $106 |
| Regeneron Healthcare Solutions, Inc. | 2 | $94 |
| VYNE Pharmaceuticals Inc. | 4 | $62 |
| AstraZeneca | 3 | $53 |
| Amgen | 3 | $49 |
| UCB, Inc. | 3 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $42 |
| Novo Nordisk | 2 | $40 |
| Boehringer Ingelheim | 2 | $36 |
| Incyte Corporation | 2 | $33 |
| Bayer | 2 | $31 |
| Dynavax Technologies Corporation | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Vertex | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,108 in reported general payments places this provider in the 95th percentile of 1,268 family providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 17 | $256,835 |
| Taltz AutoinjectorIxekizumab | 26 | $238,549 |
| Dupixent PenDupilumab | 32 | $129,605 |
| Clobetasol Propionate | 66 | $2,791 |
| Fluorouracil | 28 | $2,324 |
| Azelaic Acid | 12 | $1,355 |
| Ketoconazole | 87 | $1,271 |
| Betamethasone Dipropionate | 20 | $928 |
| Doxycycline Monohydrate | 20 | $787 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 18 | $364 |
| Triamcinolone Acetonide | 31 | $199 |
| Hydrocortisone | 16 | $129 |
Paid to pharmacies, not to this prescriber.
Other family in Tama
- Christa SlagleTama$5K
- Sherri VeselyTama$5K
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.